Strategies to Ensure Market Success of a Rare Disease Product Launch

Small patient populations, complex administration, high costs of therapies, and government policy interventions are just a few obstacles in rare disease.

EVERSANA’s Managing Director, Bill O’Bryon, and Senior Director, Diann Johnson, outline key insights to consider in your launch strategy:

1. Market dynamics impacting rare disease therapies
2. The entire rare community: patients, caregivers, providers & advocates
3. Payer landscape and engagement
4. Patient experience
5. Stakeholder relationships

Watch the Webinar: Strategies to Ensure Market Success of a Rare Disease Product Launch

Author

Managing Director, Digital

• 

Bill brings more than 15 years of experience in all facets of digital strategy, production, and measurement. He has expertise in social media, interactive marketing, content strategy, search engine optimization for branded and unbranded…